Restless Legs Syndrome: A Review of Diagnosis and Management in Primary Care

References

• . Allen RP, Walters AS, Montplaisir J, . Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286–1292
   PubMedGoogle Scholar
• . Earley CJ, Allen RP, Hening W. Restless legs syndrome and periodic leg movements in sleep. Handb Clin Neurol. 2011;99:913–948
   PubMedGoogle Scholar
• . Earley CJ, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med. 2010;11(9):807–815
   PubMed Web of Science ®Google Scholar
• . Hening WA, Walters AS, Wagner M, . Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep. 1999;22(7):901–912
   PubMed Web of Science ®Google Scholar
• . Michaud M, Dumont M, Paquet J, Desautels A, Fantini ML, Montplaisir J. Circadian variation of the effects of immobility on symptoms of restless legs syndrome. Sleep. 2005;28(7):843–846
   PubMed Web of Science ®Google Scholar
• . Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6(6):337–346
   PubMed Web of Science ®Google Scholar
• . Chaudhuri KR, Forbes A, Grosset D, . Diagnosing restless legs syndrome (RLS) in primary care. Curr Med Res Opin. 2004;20(11):1785–1795
   PubMed Web of Science ®Google Scholar
• . Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–119
   PubMed Web of Science ®Google Scholar
• . Innes KE, Seife TK, Agarwal P. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med. 2011;12(7):623–634
   PubMed Web of Science ®Google Scholar
• . Nichols DA, Allen RP, Grauke JH, . Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med. 2003;163(19):2323–2329
   PubMedGoogle Scholar
• . Allen RP, Bharmal M, Calloway M. Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord. 2011;26(1):114–120
   PubMed Web of Science ®Google Scholar
• . Allen RP, Stillman P, Myers AJ. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics. Sleep Med. 2010;11(1):31–37
   PubMed Web of Science ®Google Scholar
• . Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237–246
   PubMed Web of Science ®Google Scholar
• . Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol. 1982;39(11):739
   PubMedGoogle Scholar
• . Garcia-Borreguero D, Stillman P, Benes H, . Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol. 2011;11:28
   PubMed Web of Science ®Google Scholar
• . Montplaisir J, Godbout R, Poirier G, Bédard MA. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol. 1986;9(5):456–463
   PubMed Web of Science ®Google Scholar
• . Trenkwalder C, Hening WA, Montagna P, . Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008;23(16):2267–2302
   PubMed Web of Science ®Google Scholar
• . Winkelman JW, Allen RP, Tenzer P, Hening W. Restless legs syndrome: nonpharmacologic and pharmacologic treatments. Geriatrics. 2007;62(10):13–16
   PubMed Web of Science ®Google Scholar
• . Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22( suppl 18):S440–S448
   PubMed Web of Science ®Google Scholar
• . Earley CJ, Connor JR, Beard JL, Clardy SL, Allen RP. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes. Sleep. 2005;28(9):1069–1075
   PubMed Web of Science ®Google Scholar
• . Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54(8):1698–1700
   PubMed Web of Science ®Google Scholar
• . Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res. 2005;14(1):43–47
   PubMed Web of Science ®Google Scholar
• . Barraud Q, Obeid I, Aubert I, . Neuroanatomical study of the All diencephalospinal pathway in the non-human primate. PLoS One. 2010;5(10):e13306
   Web of Science ®Google Scholar
• . Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003;133(5 suppl 1):1468S–1472S
   PubMed Web of Science ®Google Scholar
• . Bianco LE, Unger EL, Earley CJ, Beard JL. Iron deficiency alters the day-night variation in monoamine levels in mice. Chronobiol Int. 2009;26(3):447–463
   PubMed Web of Science ®Google Scholar
• . Bianco LE, Wiesinger J, Earley CJ, Jones BC, Beard JL. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats. J Neurochem. 2008;106(1):205–215
   PubMed Web of Science ®Google Scholar
• . Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67(1):125–130
   PubMed Web of Science ®Google Scholar
• . Ondo WG, Zhao HR Le WD. Animal models of restless legs syndrome. Sleep Med. 2007;8(4):344–348
   PubMed Web of Science ®Google Scholar
• . Unger EL, Earley CJ, Beard JL. Diurnal cycle influences peripheral and brain iron levels in mice. J Appl Physiol. 2009;106(1):187–193
   PubMed Web of Science ®Google Scholar
• . Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263–265
   PubMed Web of Science ®Google Scholar
• . Connor JR, Boyer PJ, Menzies SL, . Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304–309
   PubMed Web of Science ®Google Scholar
• . Earley CJ, Kuwabara H, Wong DF, . The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep. 2011;34(3):341–347
   PubMed Web of Science ®Google Scholar
• . Godau J, Klose U, Di Santo A, Schweitzer K, Berg D. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord. 2008;23(8):1184–1187
   PubMed Web of Science ®Google Scholar
• . Schmidauer C, Sojer M, Seppi K, . Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol. 2005;58(4):630–634
   PubMed Web of Science ®Google Scholar
• . Schormair B, Kemlink D, Roeske D, . PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet. 2008;40(8):946–948
   PubMed Web of Science ®Google Scholar
• . Stefansson H, Rye DB, Hicks A, . A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357(7):639–647
   PubMed Web of Science ®Google Scholar
• . Winkelmann J, Schormair B, Lichtner P, . Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000–1006
   PubMed Web of Science ®Google Scholar
• . Benes H, Walters AS, Allen RP, Hening WA Konnen R. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22( suppl 18):S401–S408
   PubMed Web of Science ®Google Scholar
• . Silber MH, Ehrenberg BL, Allen RP, ; Medical Advisory Board of The Restless Legs Syndrome Foundation. An algorithm for the management of restless legs syndrome. Mayo Clin Proc. 2004;79(7):916–922
   PubMed Web of Science ®Google Scholar
• . Pereira JC Jr, Pradella-Hallinan M, Lins Pessoa HD. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo). 2010;65(5):548–554
   PubMed Web of Science ®Google Scholar
• . Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespérance P. Clinical, Polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61–65
   PubMed Web of Science ®Google Scholar
• . Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32(5):589–597
   PubMed Web of Science ®Google Scholar
• . Scofield H, Roth T, Drake C. Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep. 2008;31(9):1221–1227
   PubMed Web of Science ®Google Scholar
• . Hening WA, Allen RP, Washburn M, Lesage SR, Earley CJ. The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions (“mimics”). Sleep Med. 2009;10(9):976–981
   PubMed Web of Science ®Google Scholar
• . Broman JE, Mallon L, Hetta J. Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden. Psychiatry Clin Neurosci. 2008;62(4):472–475
   PubMed Web of Science ®Google Scholar
• . Rijsman R, Neven AK, Graffelman W, Kemp B, de Weerd A. Epidemiology of restless legs in The Netherlands. Eur J Neurol. 2004;11(9):607–611
   PubMed Web of Science ®Google Scholar
• . Bogan RK. Effects of restless legs syndrome (RLS) on sleep. Neuropsychiatr Dis Treat. 2006;2(4):513–519
   PubMedGoogle Scholar
• . Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract. 2004;17(5):309–318
   PubMedGoogle Scholar
• . Weber GA, Sloan P, Davies D. Nutritionally induced peripheral neuropathies. Clin Podiatr Med Surg. 1990;7(1):107–128
   PubMedGoogle Scholar
• . Gamaldo CE, Earley CJ. Restless legs syndrome: a clinical update. Chest. 2006;130(5):1596–1604
   PubMed Web of Science ®Google Scholar
• . Banks S, Dinges DF. Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med. 2007;3(5):519–528
   PubMed Web of Science ®Google Scholar
• . Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7(7):545–552
   PubMed Web of Science ®Google Scholar
• . Winkelman JW, Redline S, Baldwin CM, Resnick HE, Newman AB, Gottlieb DJ. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep. 2009;32(6):772–778
   PubMed Web of Science ®Google Scholar
• . Cho SJ, Hong JP, Hahm BJ, . Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep. 2009;32(8):1069–1076
   PubMed Web of Science ®Google Scholar
• . Scholz H, Benes H, Happe S, Bengel J, Kohnen R, Hornyak M. Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study. Health Qual Life Outcomes. 2011;9:73
   PubMed Web of Science ®Google Scholar
• . Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16(6):1159–1163
   PubMed Web of Science ®Google Scholar
• . Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70(1):35–42
   PubMed Web of Science ®Google Scholar
• . Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest. 2006;129(1):76–80
   PubMed Web of Science ®Google Scholar
• . Drake C, Roehrs T, Breslau N, . The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. Sleep. 2010;33(6):745–752
   PubMed Web of Science ®Google Scholar
• . Melamed S, Oksenberg A. Excessive daytime sleepiness and risk of occupational injuries in non-shift daytime workers. Sleep. 2002;25(3):315–322
   PubMed Web of Science ®Google Scholar
• . Abetz L, Allen R, Follet A, . Evaluating the quality of life of patients with restless legs syndrome. Clin Ther. 2004;26(6):925–935
   PubMed Web of Science ®Google Scholar
• . Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs. 2010;24(2):89–98
   PubMed Web of Science ®Google Scholar
• . Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005;28(7):891–898
   PubMed Web of Science ®Google Scholar
• . Lee HB, Hening WA, Allen RP, . Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008;20(1):101–105
   PubMed Web of Science ®Google Scholar
• . Winkelmann J, Prager M, Lieb R, . “Anxietas tibiarum”. Depression and anxiety disorders in patients with restless legs syndrome. J Neurol. 2005;252(1):67–71
   PubMed Web of Science ®Google Scholar
• . Kagimura T, Nomura T, Kusumi M, Nakashima K, Inoue Y. Prospective survey on the natural course of restless legs syndrome over two years in a closed cohort. Sleep Med. 2011;12(9):821–826
   PubMed Web of Science ®Google Scholar
• . Batool-Anwar S, Malhotra A, Forman J, Winkelman J, Li Y, Gao X. Restless legs syndrome and hypertension in middle-aged women. Hypertension. 2011;58(5):791–796
   PubMed Web of Science ®Google Scholar
• . Ali NJ, Davies RJ, Fleetham JA, Stradling JR. Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep. 1991;14(2):163–165
   PubMed Web of Science ®Google Scholar
• . Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology. 2007;68(15):1213–1218
   PubMed Web of Science ®Google Scholar
• . Walters AS, LeBrocq C, Dhar A, ; International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121–132
   PubMed Web of Science ®Google Scholar
• . Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 1996;19(3):205–213
   PubMed Web of Science ®Google Scholar
• . Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep. 1996;19(10):801–810
   PubMed Web of Science ®Google Scholar
• . García-Borreguero D, Williams AM. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev. 2010;14(5):339–346
   PubMed Web of Science ®Google Scholar
• . Boroojerdi B, Wolff HM, Braun M, Scheller DK. Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome. Drugs Today (Bare). 2010;46(7):483–505
   PubMed Web of Science ®Google Scholar
• . Eishoff JP, Braun M, Andreas JO, Middle M, Cawello W. Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies. Clin Ther. 2012;34(4):966–978
   PubMed Web of Science ®Google Scholar
• . Allen R, Becker PM, Bogan R, . Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep. 2004;27(5):907–914
   PubMed Web of Science ®Google Scholar
• . Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY; TREAT RLS US Study Group. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006;81(1):17–27
   PubMed Web of Science ®Google Scholar
• . Montplaisir J, Karrasch J, Haan J, Vole D. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord. 2006;21(10):1627–1635
   PubMed Web of Science ®Google Scholar
• . Trenkwalder C, Garcia-Borreguero D, Montagna P, ; Therapy with Ropiunirole; Efficacy and Tolerability in RLS 1 Study Group. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75(1):92–97
   PubMed Web of Science ®Google Scholar
• . Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K; TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19(12):1414–1423
   PubMed Web of Science ®Google Scholar
• . Ferini-Strambi L, Aarskog D, Partinen M, . Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Med. 2008;9(8):874–881
   PubMed Web of Science ®Google Scholar
• . Hogl B, Garcia-Borreguero D, Trenkwalder C, . Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep Med. 2011;12(4):351–360
   PubMed Web of Science ®Google Scholar
• . Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology. 1999;52(5):938–943
   PubMed Web of Science ®Google Scholar
• . Partinen M, Hirvonen K, Jama L, . Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a Polysomnographic dose-finding study—the PRELUDE study. Sleep Med. 2006;7(5):407–417
   PubMed Web of Science ®Google Scholar
• . Stiasny-Kolster K, Oertel WH. Low-dose pramipexole in the management of restless legs syndrome. An open label trial. Neuropsychobiology. 2004;50(1):65–70
   PubMed Web of Science ®Google Scholar
• . Winkelman JW, Sethi KD, Kushida CA, . Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 2006;67(6):1034–1039
   PubMed Web of Science ®Google Scholar
• . Hening WA, Allen RP, Ondo WG, ; SP792 Study Group. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord. 2010;25(11):1675–1683
   PubMed Web of Science ®Google Scholar
• . Oertel WH, Benes H, Garcia-Borreguero D, ; Rotigotine SP 709 Study Group. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med. 2008;9(3):228–239
   PubMed Web of Science ®Google Scholar
• . Oertel WH, Benes H, Garcia-Borreguero D, . Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled Polysomnographic study. Sleep Med. 2010;11(9):848–856
   PubMed Web of Science ®Google Scholar
• . Trenkwalder C, Benes H, Poewe W, ; SP790 Study Group. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2008;7(7):595–604
   PubMed Web of Science ®Google Scholar
• . Garcia-Borreguero D, Grunstein R, Sridhar G, . A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Med. 2007;8(7–8):742–752
   PubMed Web of Science ®Google Scholar
• . Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T. Long-term open-label study of pramipexole in patients with primary restless legs syndrome. J Neurol Sci. 2010;294(1–2):62–66
   PubMed Web of Science ®Google Scholar
• . Partinen M, Hirvonen K, Jama L, . Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study). Sleep Med. 2008;9(5):537–541
   PubMed Web of Science ®Google Scholar
• . Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord. 2006;21(9):1404–1410
   PubMed Web of Science ®Google Scholar
• . Oertel W, Trenkwalder C, Beneš H, . Long-term safety and efficacy of rotigotine transdermal system in moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. Lancet Neurol. 2011;10(8):710–720
   PubMed Web of Science ®Google Scholar
• . Montagna P, Hornyak M, Ulfberg J, . Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood. Sleep Med. 2011;12(1):34–40
   PubMed Web of Science ®Google Scholar
• . Benes H, Mattern W, Peglau I, . Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study. J Neurol. 2011;258(6):1046–1054
   PubMed Web of Science ®Google Scholar
• . Hornyak M, Trenkwalder C, Kohnen R, Scholz H. Efficacy and safety of dopamine agonists in restless legs syndrome. Sleep Med. 2012;13(3):228–236
   PubMed Web of Science ®Google Scholar
• . Quilici S, Abrams KR, Nicolas A, . Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Sleep Med. 2008;9(7):715–726
   PubMed Web of Science ®Google Scholar
• . Chokroverty S. Long-term management issues in restless legs syndrome. Mov Disord. 2011;26(8):1378–1385
   PubMed Web of Science ®Google Scholar
• . Kurlan R, Richard IH, Deeley C. Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation. J Gen Intern Med. 2006;21(12):C1–C4
   PubMedGoogle Scholar
• . García-Borreguero D, Allen RP, Kohnen R, ; International Restless Legs Syndrome Study Group. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007;8(5):520–530
   PubMed Web of Science ®Google Scholar
• . Högl B, García-Borreguero D, Kohnen R, . Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010;257(2):230–237
   PubMed Web of Science ®Google Scholar
• . Silber MH, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep. 2003;26(7):819–821
   PubMed Web of Science ®Google Scholar
• . Winkelman JW, Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med. 2004;5(1):9–14
   PubMed Web of Science ®Google Scholar
• . García-Borreguero D, Högl B, Ferini-Strambi L, . Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks. Mov Disord. 2012;27(2):277–283
   PubMed Web of Science ®Google Scholar
• . Bogan RK, Bornemann MA, Kushida CA, Trân PV, Barrett RW; XP060 Study Group. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study. Mayo Clin Proc. 2010;85(6):512–521
   PubMed Web of Science ®Google Scholar
• . Kushida CA, Walters AS, Becker P, ; XP021 Study Group. A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome. Sleep. 2009;32(2):159–168
   PubMed Web of Science ®Google Scholar
• . Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW; XP053 Study Group. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. J Clin Sleep Med. 2011;7(3):282–292
   PubMed Web of Science ®Google Scholar
• . Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Mov Disord. 2011;26(11):2065–2072
   PubMed Web of Science ®Google Scholar
• . Walters AS, Wagner ML, Hening WA, . Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993;16(4):327–332
   PubMed Web of Science ®Google Scholar
• . Peled R, Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. J Neurol Neurosurg Psychiatry. 1987;50(12):1679–1681
   PubMed Web of Science ®Google Scholar
• . Bezerra ML, Martinez JV. Zolpidem in restless legs syndrome. Eur Neurol. 2002;48(3):180–181
   PubMed Web of Science ®Google Scholar
• . Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T; ZOLONG Study Group. Long-term efficacy and safety of Zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31(1):79–90
   PubMed Web of Science ®Google Scholar
• . Hoque R, Chesson AL Jr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med. 2010;6(1):79–83
   PubMed Web of Science ®Google Scholar
• . Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53(1):547–554
   PubMed Web of Science ®Google Scholar
• . Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160(14):2137–2141
   PubMedGoogle Scholar
• . Rottach KG, Schaner BM, Kirch MH, . Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2008;43(1):70–75
   PubMed Web of Science ®Google Scholar